Biotech5 years ago
Swiss biotech companies are trying to find an antidote for Alzheimer’s disease
EPFL spin-off GliaPharm announced a $1.55 million (CHF 1.5 million) fund raising from the American company Gliaven LLC, bringing the total amount raised by the biotech...